Summary
Boston Scientific Corporation (BSX) announced the completion of its acquisition of the American Medical Systems (AMS) male urology portfolio on August 3, 2015. This strategic move, which includes the Men's Health and Prostate Health businesses, was initially announced on March 2, 2015. The acquisition is expected to enhance Boston Scientific's offerings and market position within the urology segment. The company issued a press release on August 4, 2015, to formally communicate this significant development to investors and stakeholders. This acquisition represents a key step in Boston Scientific's ongoing efforts to expand its product lines and strengthen its presence in specialized medical device markets.
Key Highlights
- 1Boston Scientific Corporation (BSX) has successfully completed the acquisition of the American Medical Systems (AMS) male urology portfolio.
- 2The acquired portfolio includes the Men's Health and Prostate Health businesses.
- 3The acquisition was finalized on August 3, 2015.
- 4The definitive purchase agreement for this acquisition was initially executed and announced on March 2, 2015.
- 5A press release announcing the completion of the acquisition was issued on August 4, 2015.
- 6This move is expected to bolster Boston Scientific's position in the urology market.